OTC Pharmaceuticals - Russia

  • Russia
  • The OTC Pharmaceuticals market in Russia is projected to generate a revenue of US$5.56bn in 2024.
  • This market is expected to grow annually by 3.14% (CAGR 2024-2029).
  • Among the various markets within this market, the Other OTC Pharmaceuticals market holds the largest market share, with a volume of US$1.67bn in 2024.
  • In comparison to other countries, the in the United States leads in terms of revenue generation, with a total of US$41,240.00m in 2024.
  • When considering the per person revenues in Russia, it amounts to US$38.61 in 2024.
  • Furthermore, it is estimated that online sales will contribute 12.32% of the total revenue in the OTC Pharmaceuticals market by 2024.
  • The demand for OTC pharmaceuticals in Russia has surged due to increasing health consciousness and self-medication practices.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in Russia is experiencing significant growth and development due to several key factors.

Customer preferences:
Russian consumers are increasingly turning to over-the-counter (OTC) pharmaceuticals for their healthcare needs. This shift in preferences can be attributed to several factors. Firstly, there is a growing awareness and acceptance of self-medication among the population. Consumers are becoming more knowledgeable about common ailments and are confident in their ability to treat minor health issues with OTC medications. Additionally, the convenience and accessibility of OTC drugs make them a popular choice for consumers. They can be purchased without a prescription, saving time and money compared to visiting a doctor.

Trends in the market:
One of the major trends in the OTC Pharmaceuticals market in Russia is the increasing demand for vitamins and dietary supplements. As the population becomes more health-conscious, there is a growing interest in preventive healthcare and wellness. Consumers are seeking out products that can support their overall well-being and boost their immune system. This trend is also driven by the aging population, as older adults are looking for ways to maintain their health and vitality. Another trend in the market is the rising popularity of natural and herbal remedies. Consumers are increasingly seeking out products that are perceived as more natural and less chemically-based. This trend is in line with the global shift towards natural and organic products.

Local special circumstances:
Russia has a unique healthcare system that influences the OTC Pharmaceuticals market. The country has a high number of pharmacies, making OTC drugs easily accessible to consumers. Additionally, the Russian government has implemented regulations to promote the use of OTC medications. This includes allowing pharmacies to sell certain prescription drugs without a doctor's prescription, further driving the demand for OTC pharmaceuticals.

Underlying macroeconomic factors:
The OTC Pharmaceuticals market in Russia is also influenced by macroeconomic factors. The country's improving economic conditions have led to an increase in disposable income among consumers. This has resulted in higher healthcare spending, including the purchase of OTC medications. Additionally, the aging population in Russia is driving the demand for OTC pharmaceuticals. As the population ages, the prevalence of chronic diseases and health conditions increases, leading to a higher demand for OTC drugs to manage these conditions. In conclusion, the OTC Pharmaceuticals market in Russia is experiencing growth and development due to changing customer preferences, including a growing acceptance of self-medication and an interest in preventive healthcare. Trends in the market include the increased demand for vitamins and dietary supplements, as well as the popularity of natural and herbal remedies. The local special circumstances, such as the accessibility of pharmacies and government regulations, also contribute to the market's development. Lastly, underlying macroeconomic factors, such as improving economic conditions and an aging population, further drive the growth of the OTC Pharmaceuticals market in Russia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)